9.16
1.55%
+0.14
전일 마감가:
$9.02
열려 있는:
$8.99
하루 거래량:
365.95K
시가총액:
$617.59M
수익:
-
순이익/손실:
$-100.70M
주가수익비율:
-4.2018
EPS:
-2.18
순현금흐름:
$-86.54M
1주 성능:
+1.89%
1개월 성능:
-6.15%
6개월 성능:
+33.92%
1년 성능:
+83.57%
ORIC Pharmaceuticals Inc Stock (ORIC) Company Profile
명칭
ORIC Pharmaceuticals Inc
전화
650-388-5600
주소
240 East Grand Avenue, 2nd Floor, South San Francisco, CA
ORIC Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-09-22 | 개시 | Wedbush | Outperform |
2023-03-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2023-03-21 | 업그레이드 | Guggenheim | Neutral → Buy |
2023-03-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
2022-07-18 | 재개 | Oppenheimer | Perform |
2022-04-04 | 업그레이드 | Citigroup | Neutral → Buy |
2022-03-25 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2022-03-22 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-03-22 | 다운그레이드 | Guggenheim | Buy → Neutral |
2022-03-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2021-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
2021-01-25 | 다운그레이드 | Citigroup | Buy → Neutral |
2020-08-13 | 개시 | Robert W. Baird | Outperform |
2020-08-06 | 업그레이드 | Citigroup | Neutral → Buy |
2020-08-03 | 개시 | H.C. Wainwright | Buy |
2020-05-19 | 개시 | Citigroup | Neutral |
2020-05-19 | 개시 | Guggenheim | Buy |
2020-05-19 | 개시 | JP Morgan | Overweight |
2020-05-19 | 개시 | Jefferies | Buy |
모두보기
ORIC Pharmaceuticals Inc 주식(ORIC)의 최신 뉴스
HC Wainwright Analysts Increase Earnings Estimates for ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
MarketBeat
(ORIC) Trading Advice - Stock Traders Daily
Stock Traders Daily
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) to Post Q2 2024 Earnings of ($0.42) Per Share, HC Wainwright Forecasts - Defense World
Defense World
Monaco Asset Management SAM Sells 104,793 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
MarketBeat
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) to Post Q1 2025 Earnings of ($0.47) Per Share, HC Wainwright Forecasts - Defense World
Defense World
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up to $9.50 - MarketBeat
MarketBeat
ORIC Pharmaceuticals Inc (ORIC) 재무 분석
ORIC Pharmaceuticals Inc (ORIC) 순이익 2024
ORIC은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -100.70M 달러로 보고했으며, 전년대비 -12.99% 감소했습니다.
ORIC Pharmaceuticals Inc (ORIC) 현금흐름 2024
2023-12-31 종료 분기에 ORIC은 현금흐름(지난 12개월)으로 -86.54M 달러를 기록했으며, 전년 대비 -12.06% 감소했습니다.
ORIC Pharmaceuticals Inc (ORIC) 주당 순이익 2024
ORIC이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -1.97달러이며, 전년 대비 +12.44% 성장했습니다.
ORIC Pharmaceuticals Inc 주식 (ORIC) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Chacko Jacob | PRESIDENT AND CEO |
Feb 07 '24 |
Sale |
12.29 |
26,042 |
320,186 |
768,544 |
Chacko Jacob | PRESIDENT AND CEO |
Feb 06 '24 |
Sale |
12.12 |
13,958 |
169,160 |
794,586 |
Multani Pratik S | Chief Medical Officer |
Dec 15 '23 |
Option Exercise |
0.00 |
14,042 |
0 |
29,091 |
Chacko Jacob | President and CEO |
Dec 15 '23 |
Option Exercise |
0.00 |
38,667 |
0 |
823,083 |
Chacko Jacob | President and CEO |
Dec 15 '23 |
Sale |
8.58 |
14,539 |
124,813 |
808,544 |
Multani Pratik S | Chief Medical Officer |
Dec 15 '23 |
Sale |
8.59 |
5,282 |
45,351 |
23,809 |
Piscitelli Dominic | Chief Financial Officer |
Dec 15 '23 |
Sale |
8.58 |
5,282 |
45,338 |
83,809 |
Chacko Jacob | President and CEO |
Jul 11 '23 |
Sale |
8.01 |
5,156 |
41,287 |
780,652 |
Chacko Jacob | President and CEO |
Jul 10 '23 |
Sale |
8.01 |
10,508 |
84,212 |
785,808 |
Chacko Jacob | President and CEO |
Jul 05 '23 |
Sale |
8.01 |
4,336 |
34,711 |
796,316 |
자본화:
|
볼륨(24시간):